Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial ...

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...

The American Cancer Society has recently updated cervical screening guidelines for HPV and cervical cancer. Here are the main ...

After a year of progress, scientists say they are on the cusp of turning AI-designed antibodies into potential therapies. In ...

In December 1954, Gertrude Elion and colleagues described a new compound they had developed that sent children with leukemia ...

The U.S. Food and Drug Administration approved an Investigational New Drug (IND) application using efficacy data solely from ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

In rodents, Amphista linked its BRD9 degrader AMX-883 to a significant improvement in survival and reduction in disease burden compared to Venclexta. Combining AMX-883 with Venclexta and azacitidine ...